CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 144 Insider Sale of Securities
- 4 Planned sale President & CEO sold 1,000 shares at $69.90 ($69,900)
- 4 Planned sale Director sold 5,700 shares at $69.72 ($397,430)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale President & CEO sold 112,870 shares at an average $65.80 ($7,426,508)
- 4 Planned sale Director sold 16,000 shares at an average $62.22 ($995,453)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 20,786 shares at an average $57.53 ($1,195,736)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 16,136 shares at an average $57.15 ($922,212)
- 4 Open-market sale President & CEO sold 115,859 shares at an average $57.58 ($6,670,604)
- 4 Open-market sale Chief Operating Officer sold 18,026 shares at an average $57.13 ($1,029,912)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 7 of 33 · 652 filings